No Data
No Data
Emerging markets stock digest: Sasmeco is rising, Mobiles temporarily hit the ceiling.
<4268> Edge Technology 509 +93 days rebound. It is well received that they have announced that they will provide an AI platform and support for AI introduction in the AI introduction project promoted by the Shiga Prefectural Government. As a certain introduction effect was seen in the PoC phase, the generated AI submitted a prompt that can be used in the systems that Shiga Prefecture has already introduced, and will be available for use in future business. AutoML is also being developed by Shiga Prefecture staff using their own data and AI.
Sasmido --- announced the development of a therapeutic app at the oral session of the American Clinical Oncology Society Annual Meeting.
On the 5th, Sasmido <4263> announced that the "Decision Support Program for Advanced Cancer Patients," which the company is conducting joint research on, was presented at the oral session of the annual meeting of the American Society of Clinical Oncology (ASCO) held on June 2. The company aims to address the social isolation and loneliness, as well as the shortage of medical and nursing care faced by cancer survivors by conducting research and development of new education approaches and digital medical technology in collaboration with Tokyo Jikei University School of Medicine.
Sustained --- Presented on the development of therapeutic applications at the 125th Annual Meeting of the Japan Society of Otorhinolaryngology Head and Neck Surgery
On the 17th, SusMed <4263> announced at the 125th Japan Society of Otorhinolaryngology Head and Neck Surgery General Meeting/Academic Lecture about a cognitive behavioral therapy application for persistent perceptual posture induced dizziness (PPPD), which is being developed in collaboration with Niigata University. The speaker was Professor Arata Horii (Niigata University Graduate School of Medical and Dental Sciences, Department of Otorhinolaryngology and Head and Neck Surgery). Cognitive behavioral therapy is an effective treatment for PPPD, and it also has the advantage that side effects specific to drug therapy are not seen
Volume change rate ranking (around 9:00) ~ C&F Logi HD, Northern Guru, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top Volume Change Rate [5/20 9:35 as of 9:35] (Last 5 Day Average Volume Comparison) Stock Code Stock Name Volume 5 Day Average Volume Volume Change Rate Stock Price Change Rate <1308> Listed TPX 2659961 107185.08 292.46% 0.00
Sustained--- Despite a 3Q decline in sales, the DTx product business promoted insurance coverage for insomnia treatment apps and preparations for product launch
Sustained <4263> announced financial results for the 3rd quarter (23/7/24 to 3/24) of the fiscal year ending 2024/6 on the 10th. Business revenue decreased 38.1% from the same period last year to 307 million yen, operating loss was 227 million yen (profit of 89 million yen in the same period last year), ordinary loss was 219 million yen (profit of 93 million yen), and quarterly net loss was 218 million yen (profit of 89 million yen). The DTx product business's business revenue was 200 million yen (400 million yen in the same period last year), and segment profit was 0
The weakening, rise in long-term US interest rates is heavy
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop softly. In the US stock market on the 10th of last weekend, the Dow average rose 125.08 dollars (+ 0.32%) to 39,512.84 dollars and continued to rise for 8 days. Expectations for a soft landing continued to support stock prices. Meanwhile, there are concerns about economic deceleration due to a drastic deterioration in the Michigan Consumer Confidence Index in May, and long-term interest rates rose in response to an increase in the expected inflation rate of the same index and hawkish statements from senior Federal Reserve (Fed) officials, and stock prices
No Data